Oral administration of the GnRH antagonist acyline, in a GIPET-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics (Q37291951)
Jump to navigation
Jump to search
scientific article published on 29 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral administration of the GnRH antagonist acyline, in a GIPET-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics |
scientific article published on 29 May 2009 |
Statements
1 reference
Oral administration of the GnRH antagonist acyline, in a GIPET-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics (English)
1 reference
John Kenneth Amory
1 reference
Thomas W Leonard
1 reference
Stephanie T Page
1 reference
Edel O'Toole
1 reference
Michael J McKenna
1 reference
William J Bremner
1 reference
29 May 2009
1 reference
1 reference
641-645
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference